Cart
sales@molnova.com
HM03
CAS No. 500565-15-1
HM03( —— )
Catalog No. M22402 CAS No. 500565-15-1
HM03 is a potent and selective inhibitor of HSPA5, and has anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 198 | In Stock |
|
| 100MG | 323 | In Stock |
|
| 200MG | 479 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHM03
-
NoteResearch use only, not for human use.
-
Brief DescriptionHM03 is a potent and selective inhibitor of HSPA5, and has anticancer activity.
-
DescriptionHM03 is a potent and selective inhibitor of HSPA5, and has anticancer activity.
-
In VitroCell Viability Assay Cell Line:HCT116 cells Concentration:0.1, 1, 10, 25, 50 μM Incubation Time:72 hours Result:Exhibited prominent inhibition effect (18% survival at 25 μM).
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSPA5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number500565-15-1
-
Formula Weight462.97
-
Molecular FormulaC26H27ClN4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (270.00 mM; Need ultrasonic)
-
SMILESCOc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(O)c(CN4CCN(C)CC4)c3)c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huang M , Li Z , Li D , et al. Structure-based design of HSPA5 inhibitors: From peptide to small molecule inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2013, 23(10):3044-3050.
molnova catalog
related products
-
HSP70-IN-27c
HSP70-IN-27c is a potent, irreversible inhibitor of Hsp70 without Hsp 90 binding activity.
-
MKT-077
MKT-077 (FJ-776) is a highly water-soluble (>200 mg/ml) rhodacyanine dye that exhibits significant antitumor activity.
-
Aminoxyrone
Aminoxyrone is a novel peptidometic C-terminal HSP90 inhibitor by targeting HSP90 dimerization via the C-terminal domain (CTD) with Kd of 27.4 uM.
